Search results for "10031 Clinic for Angiology"

showing 10 items of 32 documents

Incidence of Stent Thrombosis after Endovascular Treatment of Iliofemoral or Caval Veins in Patients with the Postthrombotic Syndrome.

2019

Abstract Background Patients with postthrombotic syndrome (PTS) treated with stents are at risk of stent thrombosis (ST). The incidence of ST in the presence and absence of anticoagulation therapy (AT) is unknown. Risk factors are not well understood. Patients and Methods From the prospective Swiss Venous Stent registry, we conducted a subgroup analysis of 136 consecutive patients with PTS. Incidence of ST was estimated from duplex ultrasound or venography, and reported for the time on and off AT. Baseline, procedural, and follow-up data were evaluated to identify factors associated with ST. Results Median follow-up was 20 (interquartile range [IQR] 9–40) months. AT was stopped in 43 (32%) …

0301 basic medicineAdultMalemedicine.medical_specialty2720 HematologyVenographySubgroup analysis610 Medicine & healthVena Cava Inferior030204 cardiovascular system & hematologyIliac VeinPostthrombotic Syndrome03 medical and health sciences0302 clinical medicineFibrinolytic AgentsInterquartile rangeRisk FactorsmedicineAlloysHumansCumulative incidenceRegistries610 Medicine & healthStrokemedicine.diagnostic_testbusiness.industryIncidence (epidemiology)10031 Clinic for AngiologyIncidenceHazard ratioEndovascular ProceduresAnticoagulantsThrombosisHematologyPhlebographyFemoral VeinMiddle Agedmedicine.diseaseConfidence intervalSurgery030104 developmental biologyTreatment OutcomeFemaleStentsbusinessSwitzerlandFollow-Up StudiesThrombosis and haemostasis
researchProduct

The Millennial Generation of Thrombosis and Hemostasis

2020

2019-20 coronavirus outbreakHemostasisCoronavirus disease 2019 (COVID-19)business.industry10031 Clinic for AngiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2720 Hematology610 Medicine & healthThrombosisHematologyBioinformaticsmedicine.diseaseThrombosisHemostasisMedicineHumansbusinessHämostaseologie
researchProduct

Course of D-Dimer and C-Reactive Protein Levels in Survivors and Nonsurvivors with COVID-19 Pneumonia: A Retrospective Analysis of 577 Patients

2020

2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)biologybusiness.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)10031 Clinic for AngiologyC-reactive protein2720 Hematology610 Medicine & healthHematologymedicine.diseasePneumoniaInternal medicineD-dimerbiology.proteinRetrospective analysisMedicinebusinessLetter to the EditorThrombosis and Haemostasis
researchProduct

Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality Database

2020

Summary Background European estimates of the burden imposed by pulmonary embolism are not available to this date. We aimed to assess pulmonary embolism-related mortality and time trends in the WHO European Region. Methods We analysed vital registration data from the WHO Mortality Database (2000–15) covering subregions of the WHO European Region: Eastern Europe, Northern Europe, Southern Europe, Western Europe, and Central Asia. Deaths were considered pulmonary embolism-related if International Classification of Disease-10 code for acute pulmonary embolism (I26) or any code for deep or superficial vein thrombosis was listed as the primary cause of death. We used locally estimated scatterplot…

AdultMalePulmonary and Respiratory MedicineAdolescentDatabases FactualSuperficial vein thrombosisPopulation610 Medicine & healthWorld Health Organizationcomputer.software_genreYoung AdultCase fatality rateHumansMedicineeducationAgedCause of deathAged 80 and overeducation.field_of_studyDatabasebusiness.industryIncidenceIncidence (epidemiology)Mortality rate10031 Clinic for AngiologyMiddle Agedmedicine.diseasePulmonary embolismEurope2740 Pulmonary and Respiratory MedicineAsia CentralFemalePulmonary EmbolismbusinesscomputerCohort study
researchProduct

Non-coronary atherosclerosis

2014

International audience; During the last decades, the clinical and research interest in atherosclerosis has been mostly focused on coronary arteries. After the publications of the European Society Guidelines and AHA/ACC Guidelines on Peripheral artery diseases, and of the Registry REduction in Atherothrombosis for Continued Health Registry, there has been an increased interest in atherosclerosis of the lower extremity arteries and its presence in multifocal disease. However, awareness in the general population and the medical community of non-coronary artery diseases, and of its major prognostic implications remain relatively low. The aim of this general review stemming out of an ESC Working…

Carotid Artery Diseasesmedicine.medical_specialtyPopulationAortic DiseasesComplex diseaseAorta Thoracic610 Medicine & healthDisease2705 Cardiology and Cardiovascular MedicinePeripheral artery circulationUpper ExtremityRenal ArteryMultifocal diseasemedicineHumansAorta AbdominalPeripheral Artery DiseaseseducationIntensive care medicineCoronary atherosclerosisPeripheral Vascular Diseaseseducation.field_of_studybusiness.industry10031 Clinic for AngiologySettore MED/11 - Malattie Dell'Apparato CardiovascolareMesenteric Arteries3. Good healthCoronary arteriesEarly Diagnosismedicine.anatomical_structureLower ExtremityAtherosclerosiPhysical therapy[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieperipheral artery circulation; atherosclerosisArtery diseasesatherosclerosisCardiology and Cardiovascular Medicinebusiness
researchProduct

Anticoagulation in splanchnic and cerebral vein thrombosis: Still groping in the dark.

2020

Cerebral veinsmedicine.medical_specialtybusiness.industrymedicine.drug_classSplanchnic Circulation10031 Clinic for Angiology2720 HematologyAnticoagulantanticoagulantvenous thromboembolism610 Medicine & healthHematologyCerebral vein thrombosisbleedingcerebral veinsplanchnic circulationsInternal medicineCardiologyCommentaryMedicineDiseases of the blood and blood-forming organsRC633-647.5businessSplanchnicVenous thromboembolismResearch and practice in thrombosis and haemostasis
researchProduct

Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000-18: an analysis of the WHO Mortality Database and of the CDC Multip…

2020

Contains fulltext : 232738.pdf (Publisher’s version ) (Closed access) BACKGROUND: Pulmonary embolism (PE)-related mortality is decreasing in Europe. However, time trends in the USA and Canada remain uncertain because the most recent analyses of PE-related mortality were published in the early 2000s. METHODS: For this retrospective epidemiological study, we accessed medically certified vital registration data from the WHO Mortality Database (USA and Canada, 2000-17) and the Multiple Cause of Death database produced by the Division of Vital Statistics of the US Centers for Disease Control and Prevention (CDC; US, 2000-18). We investigated contemporary time trends in PE-related mortality in th…

MaleVascular damage Radboud Institute for Health Sciences [Radboudumc 16]computer.software_genre0302 clinical medicineRisk FactorsCause of DeathEpidemiologyMedicine030212 general & internal medicineYoung adultChildCOVIDCause of deathAged 80 and overeducation.field_of_studyDatabaseMortality rateAge FactorsArticlesMiddle AgedPulmonary embolismDatabases as TopicChild PreschoolFemaleAdultPulmonary and Respiratory MedicineCanadamedicine.medical_specialtyAdolescentPopulation610 Medicine & healthSubgroup analysisWorld Health OrganizationYoung Adult03 medical and health sciencesSex FactorsHumanseducationAgedRetrospective Studiesbusiness.industry10031 Clinic for AngiologyInfant NewbornInfantRetrospective cohort studymedicine.diseaseUnited States030228 respiratory system2740 Pulmonary and Respiratory MedicinePulmonary Embolismbusinesscomputer
researchProduct

Sex-specific differences in chronic thromboembolic pulmonary hypertension. Results from the European CTEPH registry

2019

BACKGROUND: Women are more susceptible than men to several forms of pulmonary hypertension, but have better survival. Sparse data are available on chronic thromboembolic pulmonary hypertension (CTEPH). METHODS: We investigated sex-specific differences in the clinical presentation of CTEPH, performance of pulmonary endarterectomy (PEA), and survival. RESULTS: Women constituted one-half of the study population of the European CTEPH registry (N = 679) and were characterized by a lower prevalence of some cardiovascular risk factors, including prior acute coronary syndrome, smoking habit, and chronic obstructive pulmonary disease, but more prevalent obesity, cancer, and thyroid diseases. The med…

Malecardiovascular risk factorsAcute coronary syndromemedicine.medical_specialtyHypertension Pulmonary2720 Hematologypulmonary endarterectomyvenous thromboembolism610 MedizinChronic thromboembolic pulmonary hypertension610 Medicine & healthEndarterectomy030204 cardiovascular system & hematologyPulmonary Arterysurvivalchronic thromboembolic pulmonary hypertension03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineInterquartile rangeInternal medicine610 Medical sciencesmedicineHumanssexRegistriesbusiness.industry10031 Clinic for AngiologyHazard ratioHematologyMiddle Agedmedicine.diseasePulmonary hypertensionObesityConfidence intervalmedicine.anatomical_structureChronic DiseasePopulation studyFemalebusinessPulmonary EmbolismArtery
researchProduct

Venous thromboembolism in patients hospitalized for hip joint replacement surgery

2020

Venous thromboembolism (VTE) is a potentially life-threatening disease. Major transient risk factors include trauma, surgery, and immobilization. Patients undergoing hip joint replacement (HJR) are characterized by a high risk of postoperative VTE, but data on the time trends of VTE rates in this population are sparse.In an analysis of the German nationwide inpatient sample, we included all hospitalizations for elective primary HJR in Germany from 2005 to 2016. Time trends of the surgical procedure, overall death rates, and VTE rates were analysed, and predictors of VTE identified.Overall, 1,885,839 inpatients with elective primary HJR (59.1% women, 51.4% ≥70 years) were included in the ana…

Malemedicine.medical_specialtyArthroplasty Replacement HipPopulation2720 Hematology610 Medicine & healthDisease030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineRisk FactorsHip replacementGermanymedicineHumanscardiovascular diseasesHospital Mortalityeducationeducation.field_of_studybusiness.industryMortality rate10031 Clinic for AngiologyCancerPerioperativeVenous ThromboembolismHematologyequipment and suppliesmedicine.diseaseSurgeryPulmonary embolismHospitalization030220 oncology & carcinogenesisFemalebusinessVenous thromboembolism
researchProduct

Sex-specific differences in the presentation, clinical course, and quality of life of patients with acute venous thromboembolism according to baselin…

2021

Abstract Introduction Sex and the presence of specific provoking risk factors, along with age, influence the presentation and prognosis of venous thromboembolism (VTE). We investigated the presentation, course and quality of life in women and men with acute VTE classified according to their VTE provoking factors. Methods PREFER in VTE is an international, non-interventional registry of patients with a first episode of acute symptomatic VTE. Baseline provoking factors were classified as follows: major transient, minor transient, active cancer, and none identifiable. The primary outcome was recurrent VTE. Quality of life and treatment satisfaction were secondary outcomes. Results Of 3,455 pat…

Malemedicine.medical_specialtyEpidemiology610 Medicine & health030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineQuality of lifeRecurrenceInternal medicineDeep vein thrombosisEpidemiologyInternal MedicineMedicineHumanscardiovascular diseases030212 general & internal medicineFirst episodeSex Characteristicsbusiness.industry10031 Clinic for AngiologyAbsolute risk reductionCancerAnticoagulantsVenous Thromboembolismequipment and suppliesmedicine.diseaseSex specificNeoplasm RecurrenceRisk factorsLocal2724 Internal MedicineQuality of LifeSexFemalePresentation (obstetrics)Neoplasm Recurrence LocalbusinessVenous thromboembolism
researchProduct